Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Dofetilide Arrhythmia Study Group.

Bashir, Y; Thomsen, P E; Kingma, J H; Møller, M; Wong, C; Cobbe, S M; Jordaens, L; Campbell, R W; Rasmussen, H S; Camm, A J

Bashir, Y; Thomsen, P E; Kingma, J H; Møller, M; Wong, C; Cobbe, S M; Jordaens, L; Campbell, R W; Rasmussen, H S; Camm, A J.

Affiliation

Bashir Y; St. George's Hospital Medical School, London, St. Bartholomew's Hospital, London, United Kingdom.

Am J Cardiol ; 76(14): 1040-4, 1995 Nov 15.

Article in En | MEDLINE | ID: mdl-7484858

Subject(s)

Anti-Arrhythmia Agents/therapeutic use; Phenethylamines/therapeutic use; Sulfonamides/therapeutic use; Tachycardia, Ventricular/drug therapy; Aged; Anti-Arrhythmia Agents/administration & dosage; Electric Stimulation; Electrophysiology; Europe; Female; Hemodynamics/drug effects; Humans; Infusions, Intravenous; Male; Middle Aged; Phenethylamines/administration & dosage; Sulfonamides/administration & dosage; Tachycardia, Ventricular/physiopathology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phenethylamines / Sulfonamides / Tachycardia, Ventricular / Anti-Arrhythmia Agents Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Am J Cardiol Year: 1995 Document type: Article Affiliation country: United kingdom Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links